Advertisement
UK markets close in 6 hours 15 minutes

  • FTSE 100

    8,079.70
    +34.89 (+0.43%)
     

  • FTSE 250

    19,787.48
    -12.24 (-0.06%)
     

  • AIM

    755.02
    +0.15 (+0.02%)
     

  • GBP/EUR

    1.1632
    +0.0004 (+0.04%)
     

  • GBP/USD

    1.2436
    -0.0017 (-0.13%)
     

  • Bitcoin GBP

    53,432.95
    +113.59 (+0.21%)
     

  • CMC Crypto 200

    1,435.12
    +11.02 (+0.77%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    82.95
    -0.41 (-0.49%)
     

  • GOLD FUTURES

    2,331.30
    -10.80 (-0.46%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,179.38
    +41.73 (+0.23%)
     

  • CAC 40

    8,118.14
    +12.36 (+0.15%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Order book for Shire's M&A bond reach US$25bn: lead

Reuters - UK Focus

By Hillary Flynn

NEW YORK, Sept 19 (IFR) - The order book for drugmaker Shire (Xetra: S7E.DE - news) 's M&A bond have reached US$25bn, one of the banks managing the deal told IFR.

The deal, expected to be up to US$12bn in size, is due to price on Monday and will help finance Shire's acquisition of Baxalta (Berlin: 9BX.BE - news) .

Bank of America Merrill Lynch, Barclays (LSE: BARC.L - news) , Morgan Stanley (Xetra: 885836 - news) are active bookrunners on the deal. (Reporting by Hillary Flynn; Editing by Natalie Harrison and Shankar Ramakrishnan)